Aletho News

ΑΛΗΘΩΣ

WHO Wants To Run the World?

By Paul Frijters, Gigi Foster, Michael Baker | Brownstone Institute | July 11, 2022

In Geneva in late May at the 75th meeting of the WHO’s decision-making body, the World Health Assembly (WHA), amendments to its International Health Regulations (IHRs) were debated and voted upon. If passed, they would grant the WHO the right to exert unconscionable pressure on countries to accept the WHO’s authority and health policy actions if the WHO decides that there is a public health threat that might spread beyond a country’s borders.

As Ramesh Thakur, the second man at the UN for years, noted, the amendments would mean “the rise of an international bureaucracy whose defining purpose, existence, powers and budgets will depend on outbreaks of pandemics, the more the better.”

This is the first clear instance of a globalist coup attempt. It would subvert national sovereignty worldwide by putting real power into the hands of an international group of bureaucrats. It has long been suspected that the authoritarian elites arisen during covid times would try to strengthen their positions by undermining nation states, and the this 75th jamboree is the first solid evidence of this being true.

What an opportunity then to see who is in the conspiring club. Who drafted the amendments? What was in them? Which individuals supported them or spoke out against them?

WHO were the conspirators?

The amendments on the table at the May WHA meeting had been transmitted to the WHO by the US Department of Health and Human Services on January 18, circulated by WHO to its member states (‘States Parties’) on January 20 and formally introduced to the WHA on April 12.

The proposals, according to an announcement on January 26, were co-sponsored by 19 countries plus the European Union. Even if some co-sponsors had little direct involvement in drafting them, they all would have approved in principle the overarching goal of tightening up the WHO’s authority over member states in the face of a public health event.

Loyce Pace, the HHS’s Assistant Secretary for Global Affairs – the leading US official nominally responsible for the proposed amendments – arrived at the Biden administration fresh from a stint as executive director of an advocacy organization called the Global Health Council.

That council receives funding from the Bill & Melinda Gates Foundation and its members include Eli Lilly, Merck, Pfizer, Abbott Labs, and Johnson & Johnson. You get the idea. Via one of the foxes-turned-chicken-guard, it appears the HHS ‘worked closely’ on these amendments with large pharmaceutical companies, who will be chomping at the bit for a more proactive (read: profitable) response to any public health emergency, real or imagined.

So the conspiring club consists primarily of the US government and its Western allies in lockstep with Big Pharma, and they are looking to undermine both the sovereignty of their own governments and that of other countries, presumably with the idea that the Western elites would do the running.

What was in them? A blizzard of acronyms and euphemisms

To understand what the US proposed at the WHA, we need first to understand how things have worked in the WHO to this point.

The IHRs in their current form have been in force as international law since June 2007. Among other things, they impose requirements on countries to detect, report and respond to ‘public health events of international concern,’ or PHEICs. The WHO Director-General consults with the state where a possible public health event has occurred, and within 48 hours they are meant to come to a mutual agreement on whether or not it actually is a PHEIC, whether or not it needs to be announced to the world as such, and what counter-measures, if any, should be taken. It’s essentially an early-warning system on major health crises. This is a good thing if it’s run by people you can trust and if it has checks and balances to rein in expansionary tendencies.

The proposed amendments would greatly strengthen the power of the WHO relative to this baseline, in a number of ways.

First, they lower the threshold for the WHO to declare a public health emergency by empowering its Regional Directors to declare a ‘public health event of regional concern’ (PHERC, italics ours) and for the WHO to put out a new thing called an ‘intermediate public health alert.’

Second, they permit the WHO to consider allegations about a public health event from non-official sources, meaning sources other than the government of the state concerned, and allow that government only 24 hours to confirm the allegations and a further 24 hours to accept the WHO’s offer of ‘collaboration.’

Collaboration is essentially a euphemism for on-site assessment by teams of WHO investigators, and concomitant pressure at the whim of WHO personnel to enact potentially far-reaching measures such as lockdowns, movement restrictions, school closures, consumption of medicines, administration of vaccines and any or all of the other social, economic, and health paraphernalia that we have come to associate with the covid circus.

Should the state’s government acceptance of the WHO’s ‘offer’ not be forthcoming, the WHO is empowered to disclose the information it has to the other 194 WHO countries, while continuing to pressure the state to yield to the WHO’s invitation to ‘collaborate.’ A non-collaborating country would risk becoming a pariah.

Third, the proposal includes a new Chapter IV, which would establish a ‘Compliance Committee’ consisting of six government-appointed experts from each WHO region tasked with permanently nosing around to ensure the member states are complying with IHR regulations.

There are more crossings-out of the existing IHR language and new language added in, but the flavour of what the US-led alliance is shooting for is a WHO that can unilaterally decide whether there is a problem and what to do about it, and can isolate countries that disagree.

Compliant WHO member states could act as a supporting cast in the isolation effort, through the distribution of their own health budgets and their ‘health-related’ policies, which would include travel and trade restrictions. The WHO would become a kind of command-and-control center for globalist agendas, pushing the produce of (Western) Big Pharma.

Why and how would this work?

We learned during covid times why it would make sense that the US and its allies are insisting on these amendments.

Lowering the bar for declaring a global (or regional) public health threat triggers a huge opportunity for Western pharmaceutical companies. As legal experts have observed: “WHO emergency declarations can trigger the fast-track development and subsequent global distribution and administration of unlicensed investigational diagnostics, therapeutics and vaccines.

This is done via the WHO’s Emergency Use Listing Procedure (EULP). The introduction of an ‘intermediate public health alert’ in particular will also further incentivise the pharmaceutical industry’s move to activate domestic fast-track emergency trial protocols as well as for advance purchase, production and stockpile agreements with governments before the existence of a concrete health threat to the world’s population has been detected, as is already the case under WHO’s EULP via the procedures developed for a ‘pre-public health emergency phase’.”

You can bet that the WHO ‘expert teams’ sent in to make on-the-ground assessments, under the banner of ‘collaboration’ with the host country experiencing the health event, will be chock-a-block with operatives from the CDC and who knows what other Western agencies, all poking around potentially sensitive facilities that a host government might justifiably claim a sovereign right to keep to itself. Likewise with the ‘Compliance Committee’ proposed by the US under the new Chapter IV of the IHRs: its government-appointed members have an open-ended brief, enshrined in international law, to be busybodies.

In layman’s terms, the WHO would be turned into an international thug, with its member states offered the role of backyard gang members.

As a bonus for Western elites, the proposals are a sneaky form of rewriting history. By cementing authority within an international organisation to determine the existence of public health crises and direct potentially draconian emergency responses, Western governments would get to enshrine and legitimise their own extreme responses to the covid outbreak, as we have pointed out previously. Their backsides would thereby be given some protection from legal challenges.

The refusniks: Developing countries

The proposals were pushed primarily by Western countries: the US was joined by Australia, the UK and the EU in arguing for passage. The resistance was led by developing countries who saw it as a colonialist ambush in which their ability to set policy and respond to health threats in a manner commensurate with their domestic situations would be overridden.

Brazil reportedly went so far as to threaten to withdraw from the WHO, and the African group of almost 50 countries, along with India, argued that the amendments were being rushed through without adequate consultation. Russia, China and Iran also objected.

Failure on the first try, but the US and its allies in the West will get more shots to push it through.

How do we expect them to do this? Well, when a proposal gets bogged down inside a giant bureaucratic machine like the WHO, the inevitable response is to set up committees to work in the background and circle back with a new set of proposals to be presented at a future meeting. True to form, a ‘working group’ and ‘expert committee’ are being assembled to accept member state proposals on IHR reform by the end of September this year. These will be ‘sifted through’ and reports will be prepared for review by the WHO’s executive board in January next year. The objective is to have a fresh set of proposals on the table when the WHA convenes for the 77th time in 2024.

Not all was lost

Salvaging something from the fact that the WHA failed to get a consensus around its biggest agenda item, the US and its allies got a small victory on the point of when they can try again – though in their desperation they needed to violate the IHRs’ own rules to accomplish it. Article 55 of the IHRs states unambiguously that a four-month notice period is required for any amendments.

In this instance, revised amendments were presented on May 24, the same day that the first lot were rejected. These were discussed, further amended on May 27 and then adopted on the same day. The approved amendments halve the two-year period for any (further) approved amendments to the IHRs to take effect. (The IHRs that came into force in 2007 were agreed to in 2005 – but under the new resolution, anything agreed to in 2024 would come into effect in 2025 rather than 2026.)

Yet, what was achieved in terms of fast-tracking the force of new amendments was lost in slow-tracking their implementation. Nations would have up to 12 months – double the previous suggestion of six months – to implement any IHR amendments that newly enter into force of law.

State of play

Where is all this going?

If the WHO takes the reins on decisions about what constitutes a health crisis, and can pressure every country into a one-size-fits-all set of responses that it, the WHO, also determines, that’s bad enough. But what about if its invitation to ‘collaborate’ with countries is backed up with teeth, such as sanctions against those who demur? And what about if it then broadens the definition of ‘public health’ by, for example, declaring that climate change falls under that definition? Or racism? Or discrimination against LBTQIA+ people? The possibilities thereby opened up for running the world are endless.

A global ‘health’ empire would bring huge harms to humanity, but a lot of power and money is pushing for it. Don’t think it can’t happen.

Paul Frijters is a Professor of Wellbeing Economics at the London School of Economics: from 2016 through November 2019 at the Center for Economic Performance, thereafter at the Department of Social Policy

July 11, 2022 Posted by | Civil Liberties, Deception, Science and Pseudo-Science | , , , , , , , , , , , , , , , | Leave a comment

J&J tried to block publication of story about its secret plan to limit baby powder lawsuit payouts

By Christina Maas | Reclaim The Net | February 6, 2022

Johnson & Johnson has been accused of trying to suppress speech by asking a judge to block the Reuters news agency from publishing a story about the pharmaceutical giant’s legal strategy to counter lawsuits claiming that its Baby Powder is a cause of cancer.

“The First Amendment is not a license to knowingly violate the law,” J&J said in a court filing in New Jersey this week.

The filing was made at the US Bankruptcy Court where the Big Pharma giant is trying to get protections from “bankruptcy” from 38,000 lawsuits alleging the company’s baby powder product was advertised as safe but had long-term cancer risks.

This week, Reuters reported that J&J had a secret plan to shift the liability from the lawsuits to a new subsidiary which would then declare bankruptcy to limit having to pay up over the cancer lawsuits.

J&J attempted to stop Reuters from publishing the story by requesting the judge intervene and issue a restraining order.

See the court filing here.

J&J accused Reuters of obtaining documents that were protected from public disclosure, demanding that Reuters return the documents and not publish any information.

The request asks for an order:

“(1) precluding the Reuters news agency from using or relying upon any documents designated as “Confidential” in this proceeding;

(2) requiring the return of any such documents; and

(3) ordering each attorney who has made an appearance in the above-captioned proceeding to submit to the Court a declaration under penalty of perjury stating whether he or she disclosed any materials designated as “Confidential” in this proceeding to Reuters (the “Motion”).”

Lawyers for Reuters, in a court filing, said that Johnson and Johnson’s request to stop the publication was “among the most extraordinary remedies a litigant can request under the law” and that the request was a “prior restraint of speech on a matter of public interest.”

After Reuters published its story, J&J withdrew their request for an immediate hearing but was “not prepared to agree” that the request about the documents was moot.

February 7, 2022 Posted by | Deception, Full Spectrum Dominance | , | 1 Comment

Bring Back the Boycott: Say ‘No’ to Big Pharma, Big Banks and Totalitarian Control

The Defender | January 4, 2022

Nearly two years into the phenomenon labeled COVID-19, more and more people recognize that a global coup d’état is underway — a push by central bankers and technocrats for “totalitarian control of your transportation, your bank account, your movement, every aspect of your life,” said Children’s Health Defense Chairman Robert F. Kennedy, Jr. in a speech he delivered in November 2021 in Milan.

Now, a year’s worth of vaccine injury data (however imperfect) is telling “a very frightening story” about the dangers of the experimental COVID shots, and is exposing the immorality of administering them to children.

As Kennedy recently argued, “Forcing an entire population to accept an arbitrary and risky medical intervention is the most intrusive and demeaning action ever imposed by the U.S. government, and perhaps any government.”

Concerned about a rapidly advancing bio-surveillance state that would like to make participation in society dependent on vaccine passports and repeat injections, many people are wondering what they can do to resist.

Kennedy described one action that is obvious, if not necessarily easy: Say no “to buying products from the companies bankrupting and seeking to control us.”

In this instance, saying “no” requires casting a wide net, boycotting not just Big Pharma offenders like Pfizer and Johnson & Johnson (J&J) — whose products fill most Americans’ medicine cabinets — but also felonious big banks angling in the shadows for complete digital control over private resources.

Boycotts are not easy, and market analysts sometimes dispute their effectiveness. On the other hand, argues Catholic writer Dusty Gates, “When we complain about something with our lips, but continue to participate in it with our pocketbooks, our complaint loses its volume and clarity.”

Taking moral responsibility “for our personal exercise of purchasing power” and withdrawing support from entities that “degrade the common good” may not be sufficient to halt tyranny in the short term, but history shows such actions can pay long-term dividends.

Remembering the boycott’s origins

It is uncertain how many people know or remember the boycott’s 19th-century Irish origins, but the 1880 tale — one of resolute determination in desperate times — offers powerful lessons that are far from outdated.

At the time, Irish tenant farmers were in the throes of a severe famine and had hit a wall in attempting to renegotiate rents with English land agent Charles Cunningham Boycott.

When Irish nationalist Charles Stewart Parnell encouraged tenants, laborers and local shopkeepers to cut the intransigent Englishman off “from all economic and social relations with the rest of the population,” the nonviolent effort was so successful — and so devastating to Boycott’s day-to-day existence — that the man ended up fleeing Ireland in disgrace.

In his 2015 essay on “why we need boycotts,” Dusty Gates noted there is a difference between what a boycott “most often is” and what a boycott “ought to be.”

Referring to the 1880 events, Gates emphasized that the reason for the Irish tenant farmers’ actions and for the boycott’s resounding success “was specifically that people were being treated unfairly” and were losing their livelihood.

With so much at stake, the boycott was “for people, not publicity.”

Reasons to boycott Pfizer

From all appearances, few of the Americans who last year accepted novel coronavirus injections paid much attention to the corporations making the jabs, instead naively accepting the companies’ “frontrunner” status as a guarantee of trustworthiness.

But while Americans might be forgiven for knowing little about secretive upstart Moderna, the public’s willingness to overlook the known and published offenses of behemoths like Pfizer and J&J is a bit more surprising.

As law firm Matthews & Associates observed in November 2020, just prior to the rollout of Pfizer’s experimental injection, “it would seem reasonable to share all the information available on a company millions of people are expected to trust with their health, perhaps their very lives.”

The firm then outlined key elements of Pfizer’s checkered history, describing it as “rife with … subterfuge and under-the-table dealing.”

In 2010, in a published paper, Canadian health economist and policy analyst Robert G. Evans summarized Pfizer’s record as one of “persistent criminal behavior.”

In a similar assessment, a Pfizer whistleblower stated, “The whole culture of Pfizer is driven by sales, and if you didn’t sell drugs illegally, you were not seen as a team player.”

A small sampling of Pfizer’s unsavory track record includes:

  • A settlement of $2.3 billion for fraudulent marketing practices in 2009 — at the time, “the largest health care fraud settlement in the history of the Department of Justice.”
  • A lengthy history of dangerous products, including ZantacLipitor and many others.
  • Additional settlements that reveal alleged patterns of racketeering and hiding important information about drug risks, sometimes for decades.
  • An “illegal trial of an unregistered drug” in infants and children in Nigeria that killed 11 children and left others with brain damage and paralysis, ultimately resulting in a $75 million settlement; Pfizer tested the drug on the children without the parents’ informed consent.
  • Recurrent problems with contamination and quality control, including disturbing reports from whistleblowers working in the plants manufacturing COVID shots.

Four years ago, Pfizer ranked dead last in a reputational rating of pharmaceutical companies and was considered one of the companies “most associated with arrogance and greed.”

But COVID shots have been very good for business. In 2020, before the Emergency Use Authorization of Pfizer’s vaccine, two products (the blood thinner Eliquis and the Prevnar-13 vaccine) accounted for more than one-fourth of the company’s total revenue.

In 2021, not only did Pfizer’s COVID injections become the year’s top-selling drug worldwide, but top executive Albert Bourla snagged CNN’s honorific of CEO of the Year.

Agreeing with Forbes “there is money to be made and influence to be gained by having people think positively of you,” Bourla gleefully told CNN, “we are enjoying high levels of corporate reputation right now. People like us.”

To keep it that way, Pfizer is now leading the charge to block legislation that would strengthen whistleblowers’ ability to expose corporate fraud. Pharmaphorum rates Pfizer as the sixth largest lobbying presence in Washington.

As recounted in The Intercept, if the whistleblower legislation were to pass, it would strengthen anti-retaliation protections “and make it more difficult for companies charged with fraud to dismiss cases on procedural grounds.”

Buttressed by a fleet of high-powered lawyers and lobbyists, Pfizer and other Big Pharma felons such as MerckAstraZenecaAmgen and Genentech — all of whom have a history of paying large settlements for healthcare fraud — are working to make sure the bill does not pass.

They may well succeed, given Pfizer stock is one of the most popular holdings of U.S. lawmakers.

Reasons to boycott J&J

By revenue, J&J was, as of 2020, the world’s largest healthcare company. The company’s combined consumer, pharmaceutical and medical devices groups have displayed steady growth since the mid-2000s, with 55% higher annual revenue in 2020 compared to 2006.

J&J, along with Pfizer, is one of U.S. lawmakers’ top stock holdings.

J&J’s growth occurred against the backdrop of an offensive history (outlined on numerous occasions by The Defender ) of civil and criminal fines and settlements related to Risperdalopioidssurgical mesh productsasbestos-tainted baby powder as well as numerous other scandals that, pre-COVID, had finally begun to make a dent in the company’s brand and reputation.

In October 2021, eager to offload its talc liabilities, J&J created a subsidiary and then promptly filed for its bankruptcy protection. In November, meanwhile, J&J announced plans — billed by Reuters as “the biggest shake-up in the U.S. company’s 135-year history — to spin off its consumer health division to focus on the pharmaceutical and medical device division.

J&J is also betting big on “novel solutions” and technologies like robotics and artificial intelligence (AI). Back in 2015, J&J announced a partnership with Google to develop AI surgical robots.

Prior to COVID, J&J had virtually no experience developing vaccines, but COVID shots have been just as good for J&J’s bottom line as for Pfizer’s.

Despite the spate of negative publicity about vaccine-related blood clots and other adverse events, which plagued J&J throughout 2021, for the 12 months ending Sep. 30, 2021, the company reported a 13.1% year-over-year increase in revenue as well as a steadily climbing stock value.

The financial outlook for J&J’s COVID shot may change in 2022, however. In mid-December, the Centers for Disease Control and Prevention (CDC) told the public it “preferentially recommends” getting a Pfizer or Moderna injection rather than J&J’s, despite all three jabs carrying similarly worrisome risks of blood-clotting disorders.

CDC continues to endorse J&J’s shot for vulnerable prison and homeless populations (or when the other two are unavailable), but one of CDC’s advisors told the press she “wouldn’t recommend [her] own family take the J&J shot.”

In addition to adverse events, J&J’s COVID shots have attracted attention for “deficiencies” at its Baltimore production plant, where its notoriously subpar contractor “accidentally” mixed up ingredients and ruined doses.

J&J’s manufacturing woes are neither new nor unique to vaccine production, however. Back in 2013, describing “poppy-seed sized bits of plastic” in infant Motrin and injectable medications marred by mold, a reporter criticized J&J’s hypocritical “warm and fuzzy” marketing, concluding that the “out of control” company had “too many subsidiaries and outsourcing of products to third-party manufacturers for responsible oversight.”

Reasons to boycott felonious banks

In CHD.TV’s new weekly series, “Financial Rebellion,’ former investment banker and Solari Inc. President Catherine Austin Fitts explained the importance of reclaiming financial independence from the “monopolizing grip of the central banks and digital currency titans.”

Fitts argued central banks are using the pandemic to engineer an all-digital control system “that will allow them to extract tax without representation” while exerting 24/7 control over our ability to transact.

Fitts explained how members of the public have a powerful tool at their disposal to disrupt the central bankers’ plans: People can stop banking with the juggernauts that are the largest shareowners of the New York Fed — for example, JPMorgan Chase, Citigroup, Goldman Sachs, Morgan Stanley and Bank of New York Mellon (as well as other megabanks such as Bank of America, Wells Fargo and State Street) — and instead reward well-managed local banks and credit unions with their business.

The New York Fed is part of the Federal Reserve System, one of 12 Federal Reserve Banks established by Congress under the Federal Reserve Act of 1913.

It is the largest of the 12 “in terms of assets and volume of activity” and, unlike the other Reserve Banks, has “unique responsibilities” that include buying and selling U.S. Treasury securities on the open market to regulate the supply of money and intervening in foreign exchange markets.

The New York Fed has exercised “unprecedented powers” since the 2008 financial crisis and has used the cover story of the pandemic to steadily broaden those powers.

The New York Fed’s ringleader bank, JPMorgan Chase, is the largest U.S. bank (when ranked by total assets), owns 62% of all stock derivatives (valued at $3.3 trillion) held at federally-insured U.S. banks and is one of the top 10 stock holdings of U.S. lawmakers.

But, like Pfizer and J&J, JPMorgan Chase is a “criminal recidivist.” The five-count felon bank facilitated “the largest Ponzi scheme in history” (the Madoff scheme) and racked up $42 billion in civil and criminal penalties between 2002 and 2019. Recent whistleblower allegations describe a culture of fraud.

Nor is JPMorgan Chase alone as an admitted felon among New York Fed member banks. In 2015, Citigroup joined JPMorgan Chase in pleading guilty to rigging foreign exchange markets. In 2020, Goldman Sachs was charged with two felony counts.

Every action counts

Academic studies show the impact of boycotts is most significant when the companies in question already have a bad reputation and a history of frequent past scandals.

This suggests that boycotting Big Pharma, which before COVID had a long-standing reputation as “the most loathed industry in the country,” ought to be an easy sell.

Although companies like Pfizer and J&J may be benefiting from a short-lived “vaccine-led reputation boost,” their COVID injections’ nontrivial dangers are becoming so evident that even the complacent may have trouble discounting the risks.

Dr. Peter McCullough described the shots as the “most dangerous biological medicinal product rollout in human history.”

For some members of the public, connecting the dots to private central banks represents a more challenging conceptual leap.

However, it is vital to recognize the unfolding global coup as an effort coordinated across multiple sectors, not least of which is the financial sector. And — as central bankers step out of their financial silos and brazenly lecture the world about getting vaccinated — their role in the engineering of tyranny is becoming ever more obvious.

Ending tyranny will require action from each of us, beginning with saying “no” to the disastrous COVID shots.

Admittedly, it may be harder to have as immediate an impact on today’s mega-corporations and billionaire tyrants as was achieved when laundresses, postal messengers and blacksmiths so effectively shunned Charles Cunningham Boycott in the 19th century.

But severing our financial — and energetic — ties with the pharma and banking entities that are harming us is still a powerful place to begin.

Boycotts, if driven by a strong “moral impetus,” can have clout.

Products and subsidiaries you can boycott

For boycotting purposes, we include below a partial list of products manufactured by Pfizer and J&J, and a selected list of their numerous acquisitions and subsidiaries.

Leading Pfizer brands:

Advil, Bextra, Celebrex, Chantix, Depo-Testosterone, Diflucan, Effexor, Eliquis, EpiPen, Ibrance, Lipitor, Lyrica, Nexium, Norvasc, Prempro, Prevnar 13, Protonix, Viagra, Xanax, Xeljanz, Xtandi, Zithromax, Zoloft

Selected Pfizer acquisitions and subsidiaries:

1968: Quigley Company

2000: Warner-Lambert

2003: Pharmacia & Upjohn

2008: Serenex

2009: ViiV Healthcare (joint venture with GSK), Wyeth

2010: King Pharmaceuticals, Meridian Medical Technologies (sold to Altaris in Nov. 2021)

2014: InnoPharma, Redvax GmbH (controlling interest)

2015: Hospira

2016: Anacor, Medivation, Treerly

2018: GSK Consumer Healthcare (joint venture with GSK)

2019: Array Biopharma, Viatris (merger of Upjohn and Mylan)

2021: Amplyx Pharmaceuticals, Arena Pharmaceuticals, Trillium Therapeutics

Leading Johnson & Johnson brands:

Aveeno, Band-Aids, Concerta, Darzalex, devices for hip and knee replacements, Elmiron, Erleada, Imbruvica, Immodium, Invega, Invokana, Levaquin, Listerine, Opsumit, Pepcid, Remicaid, Reminyl, Risperdal, Stelara, surgical mesh products, Symtuza, Topamax, Tremfya, Tylenol, Uptravi, vision care products, Xarelto, Zyrtec, Zytiga

Selected J&J acquisitions and subsidiaries:

1947: Ethicon

1959: Cilag, McNeil

1961: Janssen Pharmaceuticals

1994: Neutrogena

1996: Cordis

1997: Biosense

1998: DePuy

2006: Animas Corporation, Pfizer Consumer Healthcare

2009: Acclarent

2010: Crucell, Micrus Endovascular

2012: Synthes

2017: Abbott Medical Optics, Actelion, TearScience

2019: Auris Health

2020: Momenta Pharmaceuticals, Verb Surgical

© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

January 4, 2022 Posted by | Corruption, Deception, Economics, Science and Pseudo-Science, Solidarity and Activism | , , | Leave a comment

Pediatricians Remove Info on Mask Risks, Dangers for Kids

By Dr. Joseph Mercola | September 20, 2021

Throughout 2020 and 2021, ever since the declared COVID-19 pandemic, government officials consistently have been inconsistent in their assessments and recommendations for public health. In August 2021, the American Academy of Pediatrics (AAP) joined the ranks when they endorsed the CDC’s recommendation for masking.1

Since they did not want to be seen holding inconsistent positions, they removed years of information from their website that explained the importance of facial cues to early brain and child development. The removal of the content culminated August 12, 2021, with the fourth in a series of tweets, in which they said:2

“Babies and young children study faces, so you may worry that having masked caregivers would harm children’s language development. There are no studies to support this concern. Young children will use other clues like gestures and tone of voice.”

At the end of the tweet, they provided a link to an article on HealthyChildren.org3 that suggested “… when one sense is taken away, the others may be heightened.” The series of tweets was aimed at masking in general, stating:4

  • Masks work to reduce the spread of COVID-19 among children
  • Masks are a vital part of keeping kids safe at school this fall
  • Masks do not compromise children’s breathing
  • Being around adults wearing masks doesn’t delay babies’ speech or language development

Experts argue over the efficacy and necessity of masking a population that has minimal risk from the virus. You need look no further than the CDC’s website,5 which shows that children ages birth to 17 had a death rate of 0.08% in 2021 and 0.05% in 2020. Yet, it was the final statement — that masking doesn’t affect children’s development — that unleashed a reaction on Twitter from parents, speech therapists and physicians who heartedly disagreed.

American Academy of Pediatrics Caught in a Quandary

To support the unsubstantiated long-term use of masks, the AAP turned their back on years of research and their own information on the importance of facial cues with infants to protect and promote brain growth and development.

To make this work, the organization has taken down significant sections from their website about early childhood development. Reuters6 asked why the content was removed the weekend after the tweets were published. They were told the content was in the process of being migrated to a different platform.

A spokesperson told Reuters, “The AAP can confirm that our web content migration has nothing to do with AAP’s mask guidance.”7 They assured Reuters the content would be republished, but were unsure about the timeline; they expect it to be complete by the end of the year.

In other words, this well-funded and organized group is coincidentally “migrating” one key section of web content that curiously contradicts their new mask guidance, and planned this so it would take months to complete.

According to Reuters,8 any links to this content that come up in the search engine are now redirected to the AAP’s homepage. However, not all the content has been deleted since other organizations use the AAP documents to educate their clients.

For example, the “Building ‘Piece’ of Mind” pdf that was pulled as a resource on the AAP website9 is available on the Ohio Bold Beginning! site and branded with the Ohio chapter of the AAP.10 You can also download the full document from an Internet archive.11

The now “migrated” document encourages parents to pay attention to their emotional responses to their children, since “Feelings are a language that your infant understands early in life.”12 Yet, without facial cues, it’s challenging for adults, much less children, to read and understand emotional reactions. In the migrated document, the AAP says:

“As your baby grows, social smiles lead to conversations. For example: When you smile, your infant will smile back … This ‘dance’ between you and your baby is fun for both of you. It is a great way to encourage your baby’s new skills as they appear. For this important dance to work, calmly and consistently meet your baby’s needs … and smile!”

But how is that supposed to work if your baby is staring at you and other adults who have two-thirds of their faces covered with masks? How do babies know you’re smiling if your entire face is covered up? In response to the AAP, Dr. James Todaro, who runs the website MedicineUncensored, tweeted:13

“AAP in 2018: ‘How Do Infants Learn? Infants love to look at you and hear your voice. In fact, faces, with all their expressions, usually are more interesting than toys. Spend time talking, singing, and laughing. Play games of touching, stroking, and peek-a-boo.’

AAP in 2021: ‘Babies and young children study faces, so you may worry that having masked caregivers would harm children’s language development. There are no studies to support this concern. Young children will use other clues like gestures and tone of voice.’”

Did Pfizer’s Funding of the AAP Influence Their Mask Policy?

Shortly after the AAP took down their facial cue documents and posted their new masking recommendations for children, a retired chief of police questioned the AAP’s motives — and in a telling opinion piece for Law Enforcement Today,14 he revealed that Pfizer is one of the AAP’s largest funders.

Twitter users15 noticed it too, with several asking what would Pfizer’s funding have to do with the AAP’s mask recommendations. Finally, one person figured it out, saying, “perhaps the plan is to get parents so fed up with their children having to wear them they break down and get them the vax.”

In fact, the AAP itself linked vaccination to mandatory mask-wearing quite clearly when they talked with NBC news,16 which reported: “The AAP said universal masking is necessary because much of the student population is not vaccinated, and it’s hard for schools to determine who is as new variants emerge that might spread more easily among children.”

When you consider that another COVID vaccine maker, Johnson & Johnson, is also a funder for the AAP — and that Dr. Anthony Fauci made the news September 9, 2021,17 saying that vaccines for children as young as 6 months may be ready as soon as November 2021 — the idea that the AAP would consider setting the stage for parents to come begging for a vaccine doesn’t sound so off the wall.

Not Just Children Are Affected

An AAP staffer was quoted in Live From Studio 6B,18 saying, “AAP recommends masks in schools and public settings to protect children. These documents are more about interactions between infants and their parents or primary caregiver, much of which will be in a home setting where masks are usually not needed.”

However, masking facial cues affects infants and young children in day care situations and when they are out of their home. This impacts “social referencing,” which the AAP finds important to child development and refers to the ability to read the face of a stranger.19

Research20 shows mothers have unique central nervous system responses when they first see the face of their newborn. This demonstrates the significance of facial cues in building mother-infant bonding. Yet, as comments on a Twitter thread point out, infants and children are not the only ones suffering from a lack of facial cues. Twitter user MDaly is a mother and teacher, who commented:21

“I teach English to students who are not native English speakers. Wearing a mask absolutely affected their language development last year. I had to ask students to repeatedly speak up and repeat themselves which negatively affects their self-esteem as well.”

A letter to the editor in The BMJ 22 expounds on the challenges faced by adults who are hearing impaired with mandatory masking. Health care has always been challenging for those with hearing impairment, especially in emergency departments where the noise level is high. Alexandra Dumitru is hearing impaired and commented:23

“Zero common sense. It’s tragic what our health institutions have become. First the CDC, now this — even adults benefit from seeing a full face. As someone hearing impaired masks have been a nightmare for me. Kids copy adults; they need to see mouths move.”

Data Are Sparse for a Very Good Reason

The AAP stated that there were no studies to support the concern that baby’s and young children’s development would be impeded by the constant use of masks in the adults who care for them. Yet, as one person on Twitter said, “If you don’t study something, you can say there are no studies.”24

However, the data are sparse and there are no studies analyzing the effect of masking on young children because before 2020 it would never have passed an ethical review board. Imagine gathering a cohort of 40 infants. Nearly from the time of birth 20 parents would wear masks anytime they had interactions with their children. The other 20 would serve as a control group, being raised in a way formerly advised by the AAP.

After five years of what could only be called abusive behavior, psychiatrists and behavior psychologists would test these children to find their brain development, language development and ability to recognize facial cues are stunted. And yet, the AAP would like us to believe that won’t happen — without testing infant development in an environment known to be detrimental, we cannot extrapolate the information and understand it would be detrimental.

In 1990, the world discovered a carefully guarded secret of the Romanian Communist Party’s leader, Nicolae Ceauşescu.25 After his execution the new government brought in Western psychologists and child specialists to help deal with the 170,000 children who were abandoned in orphanages where they received no interaction with adults.

Charles A. Nelson III, a professor of pediatrics and neuroscience at Harvard Medical School and Boston Children’s Hospital, recounts his introduction to the environment these children lived in. He recalled:26

“I walked into an institution in Bucharest one afternoon, and there was a small child standing there sobbing. He was heartbroken and had wet his pants. I asked, ‘What’s going on with that child?’ A worker said, ‘Well, his mother abandoned him this morning and he’s been like that all day.’ That was it. No one comforted the little boy or picked him up. That was my introduction.”

The children in the orphanages of Romania not only didn’t have “face time” with their caregivers, but also didn’t have any comfort or interaction. It’s not hard to imagine how an infant, who relies on cues from other people to learn and grow, could be stunted by having little exposure to facial expressions.

The Still Face Experiment

The horrific environment these children and young adults lived in was the largest human experiment in which children did not receive interaction from other humans. Until, that is, 2020 and 2021, when many infants and children are being raised in an environment where they are unable to read facial cues. In this short video, you’ll see what happens during the “still face” experiment when the infant does not get a response from the mother.

The still face experiment demonstrated how infants are vulnerable to the emotional or nonemotional reactions of people. In the COVID-19 pandemic, infants and children are lacking visual facial cues, but the expectation is they continue to receive emotional interaction at the same level they did before the mask mandates.

Research has demonstrated that when parents struggle to be emotionally present with their children, the children grow up having more trouble with trust and regulating their own emotions.27 However, there has been no data before 2020 to determine if masking facial cues would cause children to grow up with the same issues.

Are Facial Cues Recognizable Through Masks?

Research produced after 2020 has demonstrated that children and adults struggle to recognize emotion in people who are masked. How this will affect overall child development and whether the children can “catch up” if mask mandates are ever removed, is yet to be determined.

For example, in one study28 published by the University of Wisconsin-Madison in December 2020, researchers engaged children ages 7 to 13 and showed them photos of people exhibiting six different emotions. Without the masks, the children identified the emotions correctly 66% of the time.29

However, when masks were in place, this dropped to between 18% and 28% for sadness, fear and anger. A second study30 in children ages 3 to 5 years demonstrated that the younger children had even more difficulty.

The data were in line with past literature that confirmed that a face mask affected understanding emotions. They found the toddlers’ performance was more influenced by a mask than older children and adults.31

Similar studies have also been performed with adults. One study32 published in September 2020 with 41 healthy adults aged 18 to 87 years presented the participants with photos of six different expressions.

When the photos were not wearing masks, the overall performance for identifying emotions was 89.5%. This dropped significantly when masks were in place. A second study33 published in Scientific Reports in 2021, analyzed the effects of masking to measure emotion recognition and trust attribution in 122 adult men and women.

The researchers found that standard masks interfered with both measures and made it more difficult to identify an individual they had already encountered when the mask was removed.

Data produced since 2020 have shown that masks do an excellent job of masking a person’s ability to read emotions, but likely do not have the same efficacy in slowing the spread of a virus. The question we therefore must ask is, what will be the long-term effect on the emotional and mental health of society as the generation of children raised without full exposure to facial cues become doctors, lawyers, businesspeople and politicians?

Sources and References

September 20, 2021 Posted by | Corruption, Deception, Science and Pseudo-Science, Timeless or most popular | , , , , | Leave a comment

FDA gives Emergent BioSolutions a consolation prize: it must throw out 60 million vaccine doses but can sell 10 million, which will be labeled as failing GMP standards

By Meryl Nass, MD | June 11, 2021

Now this is a really odd FDA decision. FDA is acknowledging that the 10 million doses it is authorizing is adulterated. But adulterated doses can’t be sold. But EUA products don’t generally get sold, except to the US government. I am scratching my head. I thought all these doses were already bought and paid for, by the taxpayer.

And there seem to be another 100 million doses about which FDA has not made up its mind.

This echoes FDA’s decision last week to license a very expensive but ineffective Alzheimer’s drug, after its advisory committee unanimously voted against it.

We always knew FDA was a political organization. But now, without Biden having appointed anyone to its helm, its decisions are wilder than ever.

From the NY Times today:

WASHINGTON — Federal regulators have told Johnson & Johnson that about 60 million doses of its coronavirus vaccine produced at a troubled Baltimore factory cannot be used because of possible contamination, according to people familiar with the situation.

The Food and Drug Administration plans to allow about 10 million doses to be distributed in the United States or sent to other countries, but with a warning that regulators cannot guarantee that Emergent BioSolutions, the company that operates the plant, followed good manufacturing practices.

The agency has not yet decided whether Emergent can reopen the factory, which has been closed for two months because of regulatory concerns, the people said.

The Johnson & Johnson doses administered in the United States so far were manufactured at the firm’s plant in the Netherlands, not by Emergent. For weeks the F.D.A. has been trying to figure out what to do about at least 170 million doses of vaccine that were left in limbo after the discovery of a major production mishap involving two vaccines manufactured at the Baltimore factory.

June 12, 2021 Posted by | Aletho News | , , , , | Leave a comment

COVID-19: RDIF Points to Absence of Long-Term Studies on Vaccines Based on Monkey Adenoviral Vectors

By Aleksandra Serebriakova – Sputnik – 09.09.2020

The third round of trials for the AstraZeneca anti-COVID-19 drug is now on pause over “potentially unexplained illness” in a participant in the UK. On 11 August, Russia registered its own Sputnik V anti-coronavirus vaccine, which is said to have been developed in a different way.

The Russian Direct Investment Fund (RDIF) the investor which has funded the development of Russia’s Sputnik V anti-coronavirus vaccine, could not comment on the halt of AstraZeneca trials, it said in a statement.

However, RDIF pointed out that the fund’s CEO Kirill Dmitriev had previously discussed the differences between the human adenoviral vector-based platform used in Russia’s Sputnik V vaccine and those used by some of their international colleagues, that rely on “novel unproven technologies such as monkey adenoviral vectors or mRNA”.

“The safety of the human adenoviral vector used in Sputnik V has been proven over decades in over 250 clinical studies, as human adenovirus has been shown to be the safest vaccine delivery mechanism and the most ‘organic for humans’, as human adenovirus has coexisted with humans for over 100,000 years,” RFID said.

Meanwhile, “mRNA and monkey adenoviral vector-based platforms have not been studied over a long period of time,” RDIF CEO Dmitriev pointed out this Tuesday.

Commenting on the so-called “pledge of safety” earlier voiced by the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi in relation to the development of the first COVID-19 vaccines, Dmitriev stressed that this plea was “insufficient” as it did not “discuss the lack of long-term studies on the carcinogenic effects and impact on fertility of newly-developed vaccine technologies”.

“Since some of the companies developing these vaccines have taken the ‘pledge of safety’, we would like to stress that public health and safety requires not only short-term evidence of a lack of serious adverse effects, but also the safety and efficacy proved by the results of long-term studies,” Dmitriev added.

AstraZeneca COVID-19 Vaccine Trials on Pause

It was revealed this week that the third round of trials for the AstraZeneca anti-COVID-19 vaccine has been halted due to a “potentially unexplained illness” which had developed in a participant in the United Kingdom, without further specifications about the nature of possible side effects. The vaccine in question was developed in partnership with Oxford University and has reportedly involved around 30,000 participants in the UK, US, Brazil and South Africa. AstraZeneca described the pause as “routine” so as to allow for a “standard review process” of “safety data”.

Russia’s First Anti-Coronavirus Vaccine

On 11 August, Russia registered the world’s first vaccine against COVID-19, called Sputnik V, which was developed by the Gamaleya National Research Centre of Epidemiology and Microbiology and the RDIF after several rounds of clinical trials. On Monday, the vaccine was made available to the public.

According to RDIF, Russia has now received requests for 1 billion doses of the vaccine; at least 20 countries, including the UAE, Saudi Arabia, Indonesia, Philippines, Mexico, Brazil and India, have expressed an interest in obtaining Sputnik V.

September 9, 2020 Posted by | Aletho News | , , , , , , , , , | Leave a comment

Johnson’s baby powder sales end in US & Canada after cancer lawsuits… but will keep selling it elsewhere

RT | May 20, 2020

Johnson & Johnson will halt all sales of its talc-based baby powder in North America, after years of lawsuits claiming the product causes cancer – but, undeterred, the firm says it won’t stop selling it to the rest of the world.

The company announced the move in a statement on Tuesday, noting that it had decided to “permanently discontinue” the baby powder in the US and Canada to “prioritize high-demand products” amid the Covid-19 pandemic, attributing the fall in sales in part to “misinformation.”

“Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the company said, adding that it would also stop selling around 100 other items in addition to the powder.

While Johnson & Johnson insists it is “steadfastly confident” in the safety of its talc-based baby powder, vowing to “vigorously defend the product” from “unfounded allegations,” the company has faced a flurry of lawsuits from customers over the years alleging the powder contains cancer-causing agents like asbestos. Though the firm has emerged victorious from some of the suits, it has also been forced to pay out massive sums to plaintiffs in others, such as a case last February in which it was ordered to shell out $750 million to four cancer patients.

Deeming the decision a “victory for public health,” the Asbestos Disease Awareness Organization slammed Johnson & Johnson for being slow to act and misleading customers, while calling on Congress to “ban asbestos once and for all.”

“Americans should be able to trust they are safe from asbestos. Johnson & Johnson [J&J] spent decades misleading the public to think their often asbestos-contaminated baby powder was safe when they knew it was not,”said the group’s president, Linda Reinstein. “A small and influential group of chemical companies in America still rely on asbestos and have stood in the way of a national ban of this deadly substance. We can’t wait for them to follow J&J and see the error of their ways.”

Despite some consumer safety advocates hailing the move as a win, however, the controversial product will continue to be sold “in other markets around the world,” Johson & Johnson said, where demand for the powder remains high and lawsuits are less common. The decision has left the company’s critics irked, some asking whether the world population beyond North America is “expendable.”

May 20, 2020 Posted by | Timeless or most popular | , | 1 Comment

Johnson & Johnson Hides Link Between Baby Powder and Ovarian Cancer

LA jury awards record $417mn in lawsuit linking J&J baby powder to cancer

RT | August 22, 2017

A jury in Los Angeles, California, has ordered Johnson & Johnson to pay a record $417 million to a woman who claimed the talc in the company’s iconic baby powder caused her ovarian cancer.

The verdict follows a series of court rulings against J&J over the product.

The plaintiff, Eva Echeverria, alleged that J&J had failed to adequately warn consumers about its talcum powder’s potential cancer risks when used for feminine hygiene.

Echeverria had used the baby powder on a daily basis since the 1950s until two years ago, according to court papers.

She was diagnosed with ovarian cancer in 2007. Her lawsuit said she developed the cancer as a “proximate result of the unreasonably dangerous and defective nature of talcum powder.”

“Mrs. Echeverria is dying from this ovarian cancer and she said to me all she wanted to do was to help the other women throughout the whole country who have ovarian cancer for using Johnson & Johnson for 20 and 30 years,” her attorney Mark Robinson said.

J&J will appeal the jury’s decision, claiming that scientific evidence supports the safety of Johnson’s baby powder, according to the company’s spokeswoman Carol Goodrich.

The Los Angeles jury verdict is the latest and largest in a series of rulings against J&J for its baby powder, the regular use of which hundreds of women claimed caused their ovarian cancer.

In May, a court in St. Louis, Missouri ordered J&J to pay over $110 million to a Virginia woman who claimed she developed ovarian cancer after decades of using its talcum powder.

Earlier, three other lawsuits in St. Louis against the company and its baby powder had similar outcomes — with juries awarding damages of $72 million, $70.1 million and $55 million, respectively.

While the verdicts were awarded to women who regularly used the company’s baby powder for feminine hygiene, the question whether the product does any harm to babies did not come up.

Over 2,000 lawsuits were filed in different US cities accusing J&J of insufficient warning to consumers about cancer risks connected to its talc-containing products.

Some of the lawsuits were tossed out. In March, a St. Louis jury rejected the claims of a Tennessee woman with ovarian and uterine cancer who blamed talcum powder for her cancers. A judge in New Jersey tossed out two similar cases saying the plaintiffs’ lawyers did not present reliable evidence linking talc to ovarian cancer.

August 21, 2017 Posted by | Corruption, Deception, Science and Pseudo-Science, Timeless or most popular, Video | , | Leave a comment

Johnson & Johnson To Pay $2.2 Billion To Settle Deceptive Marketing Claims

By Chris Morran | Consumerist | November 4, 2013

For nearly a decade, various state and federal agencies have been looking into Johnson & Johnson’s marketing of the drugs Risperdal, Invega, Natrecor, and others, claiming the company was putting consumers at risk by paying kickbacks to doctors and pharmacists to suggest these drugs to patients and for pushing unapproved uses for these medications. Today, the Justice Dept. announced that J&J will pay out more than $2.2 billion to settle these claims.

The DOJ alleges that Johnson & Johnson subsidiary Janssen Pharmaceuticals violated the Food, Drug, and Cosmetic Act by introducing the anti-psychotic drug Risperdal — which had only been approved for the treatment of schizophrenia — into the market for unapproved uses, like the treatment of dementia and other non-schizophrenic conditions.

Johnson & Johnson and Janssen Pharmaceuticals are also accused of promoting Risperdal and another anti-psychotic, Invega, to doctors and nursing homes as a way to control behavioral disturbances in elderly dementia patients, children, and the mentally disabled. The drug makers allegedly failed to mention — or downplayed — possible side effects of Risperdal, like the risk of stroke in elderly patients.

Additionally, the DOJ accuses the companies of paying kickbacks to doctors in order to urge them to prescribe these drugs, while also kicking back money to the nation’s largest long-term care pharmacy in order to get pharmacists to recommend off-label use of Risperdal for nursing home patients who exhibited behavioral symptoms associated with Alzheimer’s Disease and dementia.

In addition to this being against the law and unethical, it meant that millions of dollars in Medicare and Medicaid payments were being paid out on prescriptions that should never have been written.

“Through these alleged actions, these companies lined their pockets at the expense of American taxpayers, patients, and the private insurance industry,” said U.S. Attorney General Eric Holder in a statement. “They drove up costs for everyone in the health care system and negatively impacted the long-term solvency of essential health care programs like Medicare.”

Holder says that J&J and Janssen will plead guilty to misbranding Risperdal, and will pay $400 million in criminal fines and forfeitures, in addition to $1.2 billion to resolve their civil liability under the False Claims Act. Johnson & Johnson will pay an additional $149 million to resolve claims relating to alleged kickbacks to a long-term care pharmacy.

But wait. There’s more.

Another J&J subsidiary, Scios, has been accused of promoting the heart drug Natrecor for off-label use without credible scientific evidence that it would have any health benefit. Scios pleaded guilty in 2009 to misbranding Natrecor and paid a criminal fine of $85 million, and along with J&J has agreed to pay an additional $184 million to resolve the latest allegations.

“Put simply, this alleged conduct is shameful and it is unacceptable,” says Holder. “It displayed a reckless indifference to the safety of the American people. And it constituted a clear abuse of the public trust, showing a blatant disregard for systems and laws designed to protect public health.”

“Today we reached closure on complex legal matters spanning almost a decade. This resolution allows us to move forward and continue to focus on delivering innovative solutions that improve and enhance the health and well-being of patients around the world,” said Michael Ullmann, Vice President and General Counsel, Johnson & Johnson, in a statement.

November 5, 2013 Posted by | Corruption, Deception, Economics | , , , , , , , | Leave a comment